258
Views
21
CrossRef citations to date
0
Altmetric
Invited Review

Tear film evaluation and management in soft contact lens wear: a systematic approach

, BOptom PhD PGCertOcTher DipMus (Prac) AMusA FACO FAAO & , BSc (Hons) MSc PhD MCOptom FAAO FBCLA FCCLSA
Pages 438-458 | Received 25 Mar 2017, Accepted 05 Jul 2017, Published online: 15 Apr 2021

REFERENCES

  • Dilly PN. Structure and function of the tear film. Adv Exp Med 1994; 350: 239–247.
  • Zhou L, Zhao SZ, Koh SK et al. In‐depth analysis of the human tear proteome. J Proteomics 2012; 75: 3877–3885.
  • Na KS, Mok JW, Kim JY, Rho CR, Joo CK. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci 2012; 53: 5443–5450.
  • Acera A, Rocha G, Vecino E, Lema I, Duran JA. Inflammatory markers in the tears of patients with ocular surface disease. Ophthalmic Res 2008; 40: 315–321.
  • Nichols JJ, Willcox MD, Bron AJ et al. The TFOS International Workshop on Contact Lens Discomfort: executive summary. Invest Ophthalmol Vis Sci 2013; 54: TFOS7–TFOS13.
  • Nichols JJ, King‐smith PE. Thickness of the pre‐ and post‐contact lens tear film measured in vivo by interferometry. Invest Ophthalmol Vis Sci 2003; 44: 68–77.
  • Chen Q, Wang J, Tao A, Shen M, Jiao S, Lu F. Ultrahigh‐resolution measurement by optical coherence tomography of dynamic tear film changes on contact lenses. Invest Ophthalmol Vis Sci 2010; 51: 1988–1993.
  • Van best JA, Benitez del castillo JM, Coulangeon LM. Measurement of basal tear turnover using a standardized protocol. European concerted action on ocular fluorometry. Graefe's Arch Ophthalmol 1995; 233: 1–7.
  • Webber WR, Jones DP, Wright P. Fluorophotometric measurements of tear turnover rate in normal healthy persons: evidence for a circadian rhythm. Eye 1987; 1 (Pt 5): 615–620.
  • Craig JP, Willcox MD, Argueso P et al. The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens interactions with the tear film subcommittee. Invest Ophthalmol Vis Sci 2013; 54: Tfos123–156.
  • Foulks GN. What is dry eye and what does it mean to the contact lens wearer? Eye Contact Lens 2003; 29: S96–100.
  • Nichols JJ, Sinnott LT. Tear film, contact lens, and patient‐related factors associated with contact lens‐related dry eye. Invest Ophthalmol Vis Sci 2006; 47: 1319–1328.
  • Nichols JJ, Ziegler C, Mitchell GL, Nichols KK. Self‐reported dry eye disease across refractive modalities. Invest Ophthalmol Vis Sci 2005; 46: 1911–1914.
  • Dumbleton K, Caffery B, Dogru M et al. The TFOS International Workshop on Contact Lens Discomfort: report of the subcommittee on epidemiology. Invest Ophthalmol Vis Sci 2013; 54: TFOS20–36.
  • Craig JP, Willcox MD, Argueso P et al. The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens interactions with the tear film subcommittee. Invest Ophthalmol Vis Sci 2013; 54: TFOS123–156.
  • Pult H, Murphy PJ, Purslow C. A novel method to predict the dry eye symptoms in new contact lens wearers. Optom Vis Sci 2009; 86: E1042–1050.
  • Blackie CA, Korb DR. A novel lid seal evaluation: the Korb‐Blackie light test. Eye Contact Lens 2015; 41: 98–100.
  • Nichols JJ, Mitchell GL, King‐smith PE. Thinning rate of the precorneal and prelens tear films. Invest Ophthalmol Vis Sci 2005; 46: 2353–2361.
  • Fonn D, Situ P, Simpson T. Hydrogel lens dehydration and subjective comfort and dryness ratings in symptomatic and asymptomatic contact lens wearers. Optom Vis Sci 1999; 76: 700–704.
  • Santodomingo‐rubido J, Wolffsohn JS, Gilmartin B. Changes in ocular physiology, tear film characteristics, and symptomatology with 18-months silicone hydrogel contact lens wear. Optom Vis Sci 2006; 83: 73–81.
  • Dogru M, Ward SK, Wakamatsu T et al. The effects of 2-week senofilcon‐A silicone hydrogel contact lens daily wear on tear functions and ocular surface health status. Cont Lens Anterior Eye 2011; 34: 77–82.
  • Glasson MJ, Hseuh S, Willcox MD. Preliminary tear film measurements of tolerant and non‐tolerant contact lens wearers. Clin Exp Optom 1999; 82: 177–181.
  • Guillon M, Maissa C. Contact lens wear affects tear film evaporation. Eye Contact Lens 2008; 34: 326–330.
  • Kojima T, Matsumoto Y, Ibrahim OM et al. Effect of controlled adverse chamber environment exposure on tear functions in silicon hydrogel and hydrogel soft contact lens wearers. Invest Ophthalmol Vis Sci 2011; 52: 8811–8817.
  • Faber E, Golding TR, Lowe R, Brennan NA. Effect of hydrogel lens wear on tear film stability. Optom Vis Sci 1991; 68: 380–384.
  • Young G, Efron N. Characteristics of the pre‐lens tear film during hydrogel contact lens wear. Ophthalmic Physiol Opt 1991; 11: 53–58.
  • Guillon M, Dumbleton KA, Theodoratos P et al. Association between contact lens discomfort and pre‐lens tear film kinetics. Optom Vis Sci 2016; 93: 881–891.
  • Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res 2004; 78: 347–360.
  • Varikooty J, Keir N, Simpson T. Estimating tear film spread and stability through tear hydrodynamics. Optom Vis Sci 2012; 89: E1119–1124.
  • Arita R, Itoh K, Inoue K, Kuchiba A, Yamaguchi T, Amano S. Contact lens wear is associated with decrease of meibomian glands. Ophthalmology 2009; 116: 379–384.
  • Machalinska A, Zakrzewska A, Adamek B et al. Comparison of morphological and functional meibomian gland characteristics between daily contact lens wearers and nonwearers. Cornea 2015; 34: 1098–1104.
  • Chen Q, Wang J, Shen M et al. Tear menisci and ocular discomfort during daily contact lens wear in symptomatic wearers. Invest Ophthalmol Vis Sci 2011; 52: 2175–2180.
  • Colorado LH, Alzahrani Y, Pritchard N, Efron N. Time course of changes in goblet cell density in symptomatic and asymptomatic contact lens wearers. Invest Ophthalmol Vis Sci 2016; 57: 2560–2566.
  • Berry M, Purslow C, Murphy PJ, Pult H. Contact lens materials, mucin fragmentation and relation to symptoms. Cornea 2012; 31: 770–776.
  • Latkovic S, Nilsson SE. The effect of high and low Dk/L soft contact lenses on the glycocalyx layer of the corneal epithelium and on the membrane associated receptors for lectins. CLAO J 1997; 23: 185–191.
  • Imayasu M, Hori Y, Cavanagh HD. Effects of multipurpose contact lens care solutions and their ingredients on membrane‐associated mucins of human corneal epithelial cells. Eye Contact Lens 2010; 36: 361–366.
  • Pritchard N, Jones L, Dumbleton K, Fonn D. Epithelial inclusions in association with mucin ball development in high‐oxygen permeability hydrogel lenses. Optom Vis Sci 2000; 77: 68–72.
  • Choy CK, Cho P, Benzie IF, Ng V. Effect of one overnight wear of orthokeratology lenses on tear composition. Optom Vis Sci 2004; 81: 414–420.
  • Van der worp E, De brabander J, Swarbrick H, Hendrikse F. Eyeblink frequency and type in relation to 3‐ and 9‐o'clock staining and gas permeable contact lens variables. Optom Vis Sci 2008; 85: E857–866.
  • Wolkoff P, Nojgaard JK, Troiano P, Piccoli B. Eye complaints in the office environment: precorneal tear film integrity influenced by eye blinking efficiency. Occup Environ Med 2005; 62: 4–12.
  • Yuksel elgin C, Iskeleli G, Talaz S, Akyol S. Comparative analysis of tear film levels of inflammatory mediators in contact lens users. Curr Eye Res 2016; 41: 441–447.
  • Willcox MD, Zhao Z, Naduvilath T, Lazon de la jara P. Cytokine changes in tears and relationship to contact lens discomfort. Mol Vis 2015; 21: 293–305.
  • Hayashi T, Fatt I. A lubrication theory model of tear exchange under a soft contact lens. Am J Optom Physiol Opt 1976; 53: 101–103.
  • Paugh JR, Stapleton F, Keay L, Ho A. Tear exchange under hydrogel contact lenses: methodological considerations. Invest Ophthalmol Vis Sci 2001; 42: 2813–2820.
  • Chen FS, Maurice DM. The pH in the precorneal tear film and under a contact lens measured with a fluorescent probe. Exp Eye Res 1990; 50: 251–259.
  • Norn MS. Tear fluid pH in normals, contact lens wearers, and pathological cases. Acta Ophthalmol 1988; 66: 485–489.
  • Ooi EH, Ng EY, Purslow C, Acharya R. Variations in the corneal surface temperature with contact lens wear. Proc Inst Mech Eng H 2007; 221: 337–349.
  • Purslow C, Wolffsohn JS, Santodomingo‐rubido J. The effect of contact lens wear on dynamic ocular surface temperature. Cont Lens Anterior Eye 2005; 28: 29–36.
  • Downie LE, Keller PR, Vingrys AJ. An evidence‐based analysis of Australian optometrists' dry eye practices. Optom Vis Sci 2013; 90: 1385–1395.
  • Graham JE, Mcgilligan VE, Berrar D et al. Attitudes towards diagnostic tests and therapies for dry eye disease. Ophthalmic Res 2010; 43: 11–17.
  • Smith J, Nichols KK, Baldwin EK. Current patterns in the use of diagnostic tests in dry eye evaluation. Cornea 2008; 27: 656–662.
  • Turner AW, Layton CJ, Bron AJ. Survey of eye practitioners' attitudes towards diagnostic tests and therapies for dry eye disease. Clin Exp Ophthalmol 2005; 33: 351–355.
  • Xue AL, Downie LE, Ormonde SE, Craig JP. A comparison of the self‐reported dry eye practices of New Zealand optometrists and ophthalmologists. Ophthalmic Physiol Opt 2017; 37: 191–201.
  • Downie LE, Rumney N, Gad A, Keller PR, Purslow C, Vingrys AJ. Comparing self‐reported optometric dry eye clinical practices in Australia and the United Kingdom: is there scope for practice improvement? Ophthalmic Physiol Opt 2016; 36: 140–151.
  • Ward SK, Dogru M, Wakamatsu T et al. Passive cigarette smoke exposure and soft contact lens wear. Optom Vis Sci 2010; 87: 367–372.
  • Stapleton F, Edwards K, Keay L et al. Risk factors for moderate and severe microbial keratitis in daily wear contact lens users. Ophthalmology 2012; 119: 1516–1521.
  • Chalmers RL, Begley CG, Moody K, Hickson‐curran SB. Contact Lens Dry Eye Questionnaire‐8 (CLDEQ‐8) and opinion of contact lens performance. Optom Vis Sci 2012; 89: 1435–1442.
  • Young G, Chalmers R, Napier L, Kern J, Hunt C, Dumbleton K. Soft contact lens‐related dryness with and without clinical signs. Optom Vis Sci 2012; 89: 1125–1132.
  • Downie LE, Keller PR, Vingrys AJ. Assessing ocular bulbar redness: a comparison of methods. Ophthalmic Physiol Opt 2016; 36: 132–139.
  • Papas EB, Vajdic C, Austen R, Holden B. High‐oxygen‐transmissiblity soft contact lenses do not induce limbal hyperemia. Curr Eye Res 1997; 16: 942–948.
  • Fonn D, Macdonald KE, Richter D, Pritchard N. The ocular response to extended wear of a high Dk silcone hydrogel contact lens. Clin Exp Optom 2002; 85: 176–182.
  • Nichols KK, Foulks GN, Bron AJ et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 2011; 52: 1922–1929.
  • Mastrota KM. Method to identify Demodex in the eyelash follicle without epilation. Optom Vis Sci 2013; 90: e172–174.
  • Song H, Zhang M, Hu X et al. Correlation analysis of ocular symptoms and signs in patients with dry eye. J Ophthalmol 2017; 2017: 1247138.
  • Katelaris CH. Giant papillary conjunctivitis‐‐a review. Acta Ophthalmol 1999: 17–20.
  • Pult H, Purslow C, Murphy PJ. The relationship between clinical signs and dry eye symptoms. Eye 2011; 25: 502–510.
  • Tomlinson A, Khanal S, Ramaesh K, Diaper C, Mcfadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci 2006; 47: 4309–4315.
  • Downie LE, Vingrys AJ. Accuracy of laboratory assays in ophthalmic practice. JAMA Ophthalmol 2015; 133: 1480.
  • Jackson D, Zeng W, Wong C et al. Tear interferon‐gamma as a biomarker for evaporative dry eye disease. Invest Ophthalmol Vis Sci 2016; 57: 4824–4830.
  • Iskeleli G, Karakoc Y, Ozkok A, Arici C, Ozcan O, Ipcioglu O. Comparison of the effects of first and second generation silicone hydrogel contact lens wear on tear film osmolarity. Int J Ophthalmol 2013; 6: 666–670.
  • Muselier‐mathieu A, Bron AM, Mathieu B et al. Ocular surface assessment in soft contact lens wearers; the contribution of tear osmolarity among other tests. Acta Ophthalmol 2014; 92: 364–369.
  • Balasubramanian SA, Pye DC, Willcox MD. Levels of lactoferrin, secretory IgA and serum albumin in the tear film of people with keratoconus. Exp Eye Res 2012; 96: 132–137.
  • Willcox MD. Is there a role for inflammation in contact lens discomfort? Eye Contact Lens 2017; 43: 5–16.
  • Alzahrani Y, Colorado LH, Pritchard N, Efron N. Longitudinal changes in Langerhans cell density of the cornea and conjunctiva in contact lens‐induced dry eye. Clin Exp Optom 2017; 100: 33–40.
  • Fleiszig SM, Efron N. Microbial flora in eyes of current and former contact lens wearers. J Clin Microbiol 1992; 30: 1156–1161.
  • Jiang Y, Jacobs M, Bajaksouzian S et al. Risk factors for microbial bioburden during daily wear of silicone hydrogel contact lenses. Eye Contact Lens 2014; 40: 148–156.
  • Watters GA, Turnbull PR, Swift S, Petty A, Craig JP. Ocular surface microbiome in meibomian gland dysfunction. Clin Exp Ophthalmol 2017; 45: 105–111.
  • Wolff E. The muco‐cutaneous junction of the lid‐margin and the distribution of the tear fluid. Trans Ophthalmol Soc UK 1946; 66: 291–308.
  • Norn MS. Semiquantitative interference study of fatty layer of precorneal film. Acta Ophthalmol 1979; 57: 766–774.
  • Butovich IA, Millar TJ, Ham BM. Understanding and analyzing meibomian lipids‐‐a review. Curr Eye Res 2008; 33: 405–420.
  • Butovich IA, Uchiyama E, Di pascuale MA, Mcculley JP. Liquid chromatography‐mass spectrometric analysis of lipids present in human meibomian gland secretions. Lipids 2007; 42: 765–776.
  • Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci 1997; 74: 8–13.
  • Thai LC. Profiling the changes in tear physiology with contact lens wear. Glasgow: Department of Vision Sciences, Glasgow Caledonian University, 2007.
  • Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous‐deficient and evaporative dry eye in a clinic‐based patient cohort: a retrospective study. Cornea 2012; 31: 472–478.
  • Lemp MA, Holly FJ, Iwata S, Dohlman CH. The precorneal tear film. I. Factors in spreading and maintaining a continuous tear film over the corneal surface. Arch Ophthalmol 1970; 83: 89–94.
  • Norn M. Dessication of the precorneal tear film I. Corneal wetting time. Acta Ophthalmol 1969; 47: 865–880.
  • Mengher LS, Bron AJ, Tonge SR, Gilbert DJ. Effect of fluorescein instillation on the pre‐corneal tear film stability. Curr Eye Res 1985; 4: 9–12.
  • Yeh TN, Graham AD, Lin MC. Relationships among Tear Film Stability, Osmolarity, and Dryness Symptoms. Optom Vis Sci 2015; 92: e264–272.
  • Mooi JK, Wang MTM, Lim J, Müller A, Craig JP. Minimising instilled volume reduces the impact of fluorescein on clinical measurements of tear film stability. Cont Lens Anterior Eye 2017; 40: 170–174.
  • Sweeney DF, Millar TJ, Raju SR. Tear film stability: a review. Exp Eye Res 2013; 117: 28–38.
  • Cho P, Douthwaite W. The relation between invasive and noninvasive tear break‐up time. Optom Vis Sci 1995; 72: 17–22.
  • Downie LE. Automated tear film surface quality breakup time as a novel clinical marker for tear hyperosmolarity in dry eye disease. Invest Ophthalmol Vis Sci 2015; 56: 7260–7268.
  • Elliott M, Fandrich H, Simpson T, Fonn D. Analysis of the repeatability of tear break‐up time measurement techniques on asymptomatic subjects before, during and after contact lens wear. Cont Lens Anterior Eye 1998; 21: 98–103.
  • Nichols JJ, Nichols KK, Puent B, Saracino M, Mitchell GL. Evaluation of tear film interference patterns and measures of tear break‐up time. Optom Vis Sci 2002; 79: 363–369.
  • Abdelfattah NS, Dastiridou A, Sadda SR, Lee OL. Noninvasive imaging of tear film dynamics in eyes with ocular surface disease. Cornea 2015; 34 Suppl 10: S48–52.
  • Hong J, Sun X, Wei A et al. Assessment of tear film stability in dry eye with a newly developed keratograph. Cornea 2013; 32: 716–721.
  • Doane MG. An instrument for in vivo tear film interferometry. Optom Vis Sci 1989; 66: 383–388.
  • Guillon JP, Guillon M. Tear film examination of the contact lens patient. Optician 1993; 206: 21–29.
  • Ruben M, Guillon M. Contact Lens Practice. London: Chapman & Hall Medical, 1994.
  • Goto E, Matsumoto Y, Kamoi M et al. Tear evaporation rates in Sjogren syndrome and non‐Sjogren dry eye patients. Am J Ophthalmol 2007; 144: 81–85.
  • Zhao Y, Tan CL, Tong L. Intra‐observer and inter‐observer repeatability of ocular surface interferometer in measuring lipid layer thickness. BMC Ophthalmol 2015; 15: 53.
  • Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci 2011; 52: 1994–2005.
  • Alghamdi WM, Markoulli M, Holden BA, Papas EB. Impact of duration of contact lens wear on the structure and function of the meibomian glands. Ophthalmic Physiol Opt 2016; 36: 120–131.
  • Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea 2008; 27: 1142–1147.
  • Meadows JF, Ramamoorthy P, Nichols JJ, Nichols KK. Development of the 4‐3‐2‐1 meibum expressibility scale. Eye Contact Lens 2012; 38: 86–92.
  • Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf 2003; 1: 107–126.
  • Tomlinson A, Bron AJ, Korb DR et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 2011; 52: 2006–2049.
  • Hagedorn S, Drolle E, Lorentz H, Srinivasan S, Leonenko Z, Jones L. Atomic force microscopy and Langmuir‐Blodgett monolayer technique to assess contact lens deposits and human meibum extracts. J Optometry 2015; 8: 187–199.
  • Pult H, Nichols JJ. A review of meibography. Optom Vis Sci 2012; 89: E760–769.
  • Pult H, Riede‐pult B. Comparison of subjective grading and objective assessment in meibography. Cont Lens Anterior Eye 2013; 36: 22–27.
  • Downie LE, Keller PR. A pragmatic approach to dry eye diagnosis: evidence into practice. Optom Vis Sci 2015; 92: 1189–1197.
  • Efron N, Jones L, Bron AJ et al. The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens interactions with the ocular surface and adnexa subcommittee. Invest Ophthalmol Vis Sci 2013; 54: Tfos98–tfos122.
  • Pult H, Riede‐pult BH, Nichols JJ. Relation between upper and lower lids' meibomian gland morphology, tear film, and dry eye. Optom Vis Sci 2012; 89: E310–315.
  • Blackie CA, Korb DR, Knop E, Bedi R, Knop N, Holland EJ. Nonobvious obstructive meibomian gland dysfunction. Cornea 2010; 29: 1333–1345.
  • Dartt DA. Dysfunctional neural regulation of lacrimal gland secretion and its role in the pathogenesis of dry eye syndromes. Ocul Surf 2004; 2: 76–91.
  • Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 2001; 45 Suppl 2: S203–210.
  • Chen Y, Mehta G, Vasiliou V. Antioxidant defenses in the ocular surface. Ocul Surf 2009; 7: 176–185.
  • Craig JP, Tomlinson A. Effect of age on tear osmolality. Optom Vis Sci 1995; 72: 713–717.
  • The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5: 75–92.
  • Liu H, Begley C, Chen M et al. A link between tear instability and hyperosmolarity in dry eye. Invest Ophthalmol Vis Sci 2009; 50: 3671–3679.
  • Garcia‐resua C, Pena‐verdeal H, Remeseiro B, Giraldez MJ, Yebra‐pimentel E. Correlation between tear osmolarity and tear meniscus. Optom Vis Sci 2014; 91: 1419–1429.
  • Ibrahim OM, Dogru M, Takano Y et al. Application of visante optical coherence tomography tear meniscus height measurement in the diagnosis of dry eye disease. Ophthalmology 2010; 117: 1923–1929.
  • Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004; 23: 762–770.
  • Chen Q, Wang J, Shen M et al. Lower volumes of tear menisci in contact lens wearers with dry eye symptoms. Invest Ophthalmol Vis Sci 2009; 50: 3159–3163.
  • Ramamoorthy P, Nichols JJ. Mucins in contact lens wear and dry eye conditions. Optom Vis Sci 2008; 85: 631–642.
  • Hu Y, Matsumoto Y, Dogru M et al. The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis. Allergy 2007; 62: 917–925.
  • Brignole F, Pisella PJ, De saint jean M, Goldschild M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in KCS: 6‐month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci 2001; 42: 90–95.
  • Nelson JD, Wright JC. Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol 1984; 102: 1049–1051.
  • Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol 2002; 120: 330–337.
  • Nelson JD. Impression cytology. Cornea 1988; 7: 71–81.
  • Millar TJ, Papas EB, Ozkan J, Jalbert I, Ball M. Clinical appearance and microscopic analysis of mucin balls associated with contact lens wear. Cornea 2003; 22: 740–745.
  • Szczotka‐flynn L, Benetz BA, Lass J et al. The association between mucin balls and corneal infiltrative events during extended contact lens wear. Cornea 2011; 30: 535–542.
  • Demirci S, Gunes A, Koyuncuoglu HR, Tok L, Tok O. Evaluation of corneal parameters in patients with Parkinson's disease. Neurol Sci 2016; 37: 1247–1252.
  • Argiles M, Cardona G, Perez‐cabre E, Rodriguez M. Blink rate and incomplete blinks in six different controlled hard‐copy and electronic reading conditions. Invest Ophthalmol Vis Sci 2015; 56: 6679–6685.
  • Craig JP, Wang MT, Kim D, Lee JM. Exploring the predisposition of the asian eye to development of dry eye. Ocul Surf 2016; 14: 385–392.
  • Ousler GW, 3rd, Hagberg KW, Schindelar M, Welch D, Abelson MB. The Ocular Protection Index. Cornea 2008; 27: 509–513.
  • Badian R, Utheim TP, Ræder s et al. Ocular protection index is related to ocular surface disease index in dry eye disease patients. Acta Ophthalmol 2014; 92: S045.
  • Efron N, Morgan PB, Katsara SS. Validation of grading scales for contact lens complications. Ophthalmic Physiol Opt 2001; 21: 17–29.
  • Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003; 22: 640–650.
  • Van bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969; 82: 10–14.
  • Lemp MA. Report of the National eye institute/ industry workshop on clinical trials in dry eyes. CLAO J 1995; 21: 221–232.
  • Korb DR, Greiner JV, Herman J. Comparison of fluorescein break‐up time measurement reproducibility using standard fluorescein strips versus the Dry Eye Test (DET) method. Cornea 2001; 20: 811–815.
  • Bron AJ, Argueso P, Irkec M, Bright FV. Clinical staining of the ocular surface: mechanisms and interpretations. Prog Ret Eye Res 2015; 44: 36–61.
  • Khan‐lim D, Berry M. Still confused about rose bengal? Current Eye Res 2004; 29: 311–317.
  • Efron N. Putting vital stains in context. Clin Exp Optom 2013; 96: 400–421.
  • Korb DR, Herman J, Greiner JV et al. Lid wiper epitheliopathy and dry eye symptoms. Eye Contact Lens 2005; 31: 2–8.
  • Yeniad B, Beginoglu M, Bilgin LK. Lid‐wiper epitheliopathy in contact lens users and patients with dry eye. Eye Contact Lens 2010; 36: 140–143.
  • Alzahrani Y, Colorado L, Pritchard N, Efron N. Inflammatory cell upregulation of the lid wiper in contact lens dry eye. Optom Vis Sci 2016; 93: 917–924.
  • Dougherty JM, Mcculley JP. Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci 1986; 27: 486–491.
  • Guillon M, Maissa C, Wong S. Eyelid margin modification associated with eyelid hygiene in anterior blepharitis and meibomian gland dysfunction. Eye Contact Lens 2012; 38: 319–325.
  • Guillon M, Maissa C, Wong S. Symptomatic relief associated with eyelid hygiene in anterior blepharitis and MGD. Eye Contact Lens 2012; 38: 306–312.
  • Khaireddin R, Hueber A. [Eyelid hygiene for contact lens wearers with blepharitis. Comparative investigation of treatment with baby shampoo versus phospholipid solution]. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2013; 110: 146–153.
  • Leibowitz HM, Capino D. Treatment of chronic blepharitis. Arch Ophthalmol 1988; 106: 720.
  • Polack FM, Goodman DF. Experience with a new detergent lid scrub in the management of chronic blepharitis. Arch Ophthalmol 1988; 106: 719–720.
  • Craig JP, Sung J, Wang MT, Cheung I, Sherwin T, Ismail S. Commercial lid cleanser outperforms baby shampoo for management of blepharitis in randomized, double‐masked clinical trial. Invest Ophthalmol Vis Sci 2017; 58: 2247.
  • Zhao YE, Wu LP, Hu L, Xu JR. Association of blepharitis with Demodex: a meta‐analysis. Ophthalmic Epidemiol 2012; 19: 95–102.
  • English FP, Nutting WB. Feeding characteristics in demodectic mites of the eyelid. Aust J Ophthalmol 1981; 9: 311–313.
  • English FP, Nutting WB, Cohn D. Eyelid mite nests. Aust J Ophthalmol 1982; 10: 187–189.
  • Gao YY, Di pascuale MA, Li W et al. In vitro and in vivo killing of ocular Demodex by tea tree oil. Br J Ophthalmol 2005; 89: 1468–1473.
  • Holzchuh FG, Hida RY, Moscovici BK et al. Clinical treatment of ocular Demodex folliculorum by systemic ivermectin. Am J Ophthalmol 2011; 151: 1030–1034.e1.
  • Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci 2011; 52: 1938–1978.
  • Korb DR, Blackie CA. Debridement‐scaling: a new procedure that increases Meibomian gland function and reduces dry eye symptoms. Cornea 2013; 32: 1554–1557.
  • Ngo W, Caffery B, Srinivasan S, Jones LW. Effect of lid debridement‐scaling in Sjogren syndrome dry eye. Optom Vis Sci 2015; 92: e316–320.
  • Ma X, Lu Y. Efficacy of intraductal meibomian gland probing on tear function in patients with obstructive meibomian gland dysfunction. Cornea 2016; 35: 725–730.
  • Wladis EJ. Intraductal meibomian gland probing in the management of ocular rosacea. Ophthalmic Plast Reconstr Surg 2012; 28: 416–418.
  • Borchman D, Foulks GN, Yappert MC et al. Human meibum lipid conformation and thermodynamic changes with meibomian‐gland dysfunction. Invest Ophthalmol Vis Sci 2011; 52: 3805–3817.
  • Geerling G, Tauber J, Baudouin C et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011; 52: 2050–2064.
  • Lacroix Z, Leger S, Bitton E. Ex vivo heat retention of different eyelid warming masks. Cont Lens Anterior Eye 2015; 38: 152–156.
  • Bilkhu PS, Naroo SA, Wolffsohn JS. Randomised masked clinical trial of the MGDRx EyeBag for the treatment of meibomian gland dysfunction‐related evaporative dry eye. Br J Ophthalmol 2014; 98: 1707–1711.
  • Wang MT, Jaitley Z, Lord SM, Craig JP. Comparison of self‐applied heat therapy for meibomian gland dysfunction. Optom Vis Sci 2015; 92: e321–326.
  • Craig JP, Blades K, Patel S. Tear lipid layer structure and stability following expression of the meibomian glands. Ophthalmic Physiol Opt 1995; 15: 569–574.
  • Korb DR, Blackie CA. Meibomian gland therapeutic expression: quantifying the applied pressure and the limitation of resulting pain. Eye Contact Lens 2011; 37: 298–301.
  • Mcpherson AT, Wu R, Oliver P, Pullen JA, Greiner JV. Daily warm compress therapy augmented with manual lid expressions vs a single thermal pulsation system treatment for evaporative dry eye disease secondary to meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2016; 5680–A0026.
  • Sim HS, Petznick A, Barbier S et al. A randomized, controlled treatment trial of eyelid‐warming therapies in meibomian gland dysfunction. Ophthalmol Ther 2014; 31: 37–48.
  • Villani E, Garoli E, Canton V, Pichi F, Nucci P, Ratiglia R. Evaluation of a novel eyelid‐warming device in meibomian gland dysfunction unresponsive to traditional warm compress treatment: an in vivo confocal study. Int Ophthalmol 2015; 35: 319–323.
  • Pult H, Riede‐pult BH, Purslow C. A comparison of an eyelid‐warming device to traditional compress therapy. Optom Vis Sci 2012; 89: E1035–1041.
  • Purslow C. Evaluation of the ocular tolerance of a novel eyelid‐warming device used for meibomian gland dysfunction. Cont Lens Anterior Eye 2013; 36: 226–231.
  • Yeo S, Tan JH, Acharya UR, Sudarshan VK, Tong L. Longitudinal changes in tear evaporation rates after eyelid warming therapies in meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2016; 57: 1974–1981.
  • Craig JP, Chen YH, Turnbull PR. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2015; 56: 1965–1970.
  • Vora GK, Gupta PK. Intense pulsed light therapy for the treatment of evaporative dry eye disease. Curr Opin Ophthalmol 2015; 26: 314–318.
  • Vegunta S, Patel D, Shen JF. Combination therapy of intense pulsed light therapy and meibomian gland expression (IPL/MGX) can improve dry eye symptoms and meibomian gland function in patients with refractory dry eye: a retrospective analysis. Cornea 2016; 35: 318–322.
  • Toyos R, Mcgill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3‐year retrospective study. Photomed Laser Surg 2015; 33: 41–46.
  • Greiner JV. Long‐term (12‐month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment. Clin Exp Ophthalmol 2013; 41: 524–530.
  • Greiner JV. A single LipiFlow(R) Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9-months. Curr Eye Res 2012; 37: 272–278.
  • Finis D, Konig C, Hayajneh J, Borrelli M, Schrader S, Geerling G. Six‐month effects of a thermodynamic treatment for MGD and implications of meibomian gland atrophy. Cornea 2014; 33: 1265–1270.
  • Patel S, Henderson R, Bradley L, Galloway B, Hunter L. Effect of visual display unit use on blink rate and tear stability. Optom Vis Sci 1991; 68: 888–892.
  • Ang CK, Mohidin N, Chung KM. Effects of wink glass on blink rate, nibut and ocular surface symptoms during visual display unit use. Curr Eye Res 2014; 39: 879–884.
  • Murakami D, Blackie CA, Korb DR. Blinking exercises can be used to decrease partial blinking and improve gland function and symptoms in patients with evaporative dry eye. Denver: American Academy of Optometry, 2014.
  • Kashkouli MB, Fazel AJ, Kiavash V, Nojomi M, Ghiasian L. Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double‐masked open‐label clinical trial. Br J Ophthalmol 2015; 99: 199–204.
  • Foulks GN, Borchman D, Yappert M, Kakar S. Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study. Cornea 2013; 32: 44–53.
  • Foulks GN, Borchman D, Yappert M, Kim SH, Mckay JW. Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations. Cornea 2010; 29: 781–788.
  • Haque RM, Torkildsen GL, Brubaker K et al. Multicenter open‐label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Cornea 2010; 29: 871–877.
  • Deinema LA, Vingrys AJ, Wong C‐Y, Jackson DC, Chinnery HR, Downie LE. A randomized, double‐masked, placebo‐controlled clinical trial of two forms of omega‐3 supplements for treating dry eye disease. Ophthalmology 2017; 124: 43–52.
  • Chinnery HR, Naranjo golborne C, Downie LE. Omega‐3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study. Ophthalmic Physiol Opt 2017; 37: 473–481.
  • Sullivan BD, Cermak JM, Sullivan RM et al. Correlations between nutrient intake and the polar lipid profiles of meibomian gland secretions in women with Sjogren's syndrome. Adv Exp Med Biol 2002; 506: 441–447.
  • Hom MM, Asbell P, Barry B. Omegas and dry eye: more knowledge, more questions. Optom Vis Sci 2015; 92: 948–956.
  • Macsai MS. The role of omega‐3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc 2008; 106: 336–356.
  • Lee SY, Tong L. Lipid‐containing lubricants for dry eye: a systematic review. Optom Vis Sci 2012; 89: 1654–1661.
  • Wang MT, Ganesalingam K, Loh CS et al. Compatibility of phospholipid liposomal spray with silicone hydrogel contact lens wear. Cont Lens Anterior Eye 2017; 40: 53–58.
  • Wan KH, Chen LJ, Young AL. Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta‐analysis. Ocul Surf 2015; 13: 213–225.
  • Wang L, Chen X, Hao J, Yang L. Proper balance of omega‐3 and omega‐6 fatty acid supplements with topical cyclosporine attenuated contact lens‐related dry eye syndrome. Inflammopharmacology 2016; 24: 389–396.
  • Giovagnoli D, Graham SJ. Inferior punctal occlusion with removable silicone punctal plugs in the treatment of dry‐eye related contact lens discomfort. J Am Optom Assoc 1992; 63: 481–485.
  • Slusser TG, Lowther GE. Effects of lacrimal drainage occlusion with nondissolvable intracanalicular plugs on hydrogel contact lens wear. Optom Vis Sci 1998; 75: 330–338.
  • Papas EB, Ciolino JB, Jacobs D et al. The TFOS International Workshop on Contact Lens Discomfort: report of the management and therapy subcommittee. Invest Ophthalmol Vis Sci 2013; 54: TFOS183–203.
  • Hartstein I, Khwarg S, Przydryga J. An open‐label evaluation of HP‐Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population. Curr Med Res Opin 2005; 21: 255–260.
  • Christensen MT. Corneal staining reductions observed after treatment with Systane Lubricant Eye Drops. Adv Ther 2008; 25: 1191–1199.
  • Ousler GW, Michaelson C, Christensen MT. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops. Cornea 2007; 26: 949–952.
  • Kading D. A two‐week clinical evaluation of the safety of Systane Ultra in contact lens‐wearing patients. Clin Ophthalmol 2010; 4: 27–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.